Texas Heart Institute

Houston, Texas 77702

6 studies enrolling now · 66 studies all time

What they study most

ADHF, Acute Coronary Syndrome, Acute Kidney Injury, Acute Renal Failure, Advanced Refractory Left Ventricular Heart Failure, Angina, Angina Pectoris, Angina Refractory, Aortic Stenosis, Aortic Valve Disease, Atherosclerotic Cardiovascular Disease, Atrial Fibrillation

Studies at this site

• Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure — Recruiting now
• A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis — Recruiting now
• Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II — Recruiting now
• Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy — Recruiting now
• A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF) — Recruiting now
• Study Assessing Left Ventricular Administration of a Genetic Medicine Directing Organ Regeneration in Heart Failure — Recruiting now
• A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination — Paused
• A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS) — Paused
• Safety and Efficacy Study of Engensis (VM202) in the Treatment of Chronic Non-Healing Foot Ulcers — Stopped early
• Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia — Completed
• Reducing Lung CongestIon Symptoms in Advanced Heart Failure — Running, not enrolling
• Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients — Running, not enrolling
• A Study on Impact of Canagliflozin on Health Status, Quality of Life, and Functional Status in Heart Failure — Completed
• FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study — Completed
• Randomized On-X Anticoagulation Trial — Completed
• Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study — Completed
• Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System — Running, not enrolling
• Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease — Running, not enrolling
• Withings ECG-app Study — Completed
• Withings ECG-Monitor Study — Completed
• Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial) — Completed
• Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy — Completed
• OPTIMIZE IDE for the Treatment of ACS — Stopped early
• MOMENTUM 3 Continued Access Protocol — Completed
• Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation — Completed
• Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy — Completed
• MOMENTUM 3 IDE Clinical Study Protocol — Completed
• Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management — Completed
• Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure — Completed
• Safety and Accuracy of the Saranas EBBMS for the Detection of Endovascular Procedure Related Bleeding Events — Completed
• Stem Cell Injection in Cancer Survivors — Completed
• A Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (ENDURANCE SUPPLEMENTAL TRIAL) — Completed
• Evaluation of the Safety and Effectiveness of the DuraHeart™ LVAS — Stopped early
• Post- Approval Study on Patients Who Received a HeartWare HVAD® During IDE Trials — Completed
• Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement — Stopped early
• Artificial Valve Endocarditis Reduction Trial — Stopped early
• Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy — Stopped early
• The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial — Completed
• The Use of CoSeal (Sealant Agent) in Patients During Left Ventricular Assist Device Surgery — Stopped early
• Evaluation of the HeartWare Left Ventricular Assist Device for the Treatment of Advanced Heart Failure — Completed
• Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure — Stopped early
• To Assess Safety and Efficacy of Myoblast Implantation Into Myocardium Post Myocardial Infarction — Status unconfirmed
• Safety Study of the Ventricular Partitioning Device (VPD) Implant System in Heart Failure Patients — Completed
• Patients With Intermittent Claudication Injected With ALDH Bright Cells — Completed
• A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery — Withdrawn before enrolling
• Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass — Completed
• Safety and Feasibility Trial of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia — Completed
• Mechanism and Repository Study for the Red Cell Storage Duration Study — Completed
• The Effects of Nitric Oxide for Inhalation During Left Ventricular Assists Device (LVAD) Implantation — Completed
• NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction — Completed